Literature DB >> 1873232

Dapsone for idiopathic autoimmune thrombocytopenic purpura in elderly patients.

J M Durand1, P Lefèvre, P Hovette, M Mongin, J Soubeyrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1873232     DOI： 10.1111/j.1365-2141.1991.tb04467.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  [Chronic idiopathic thrombocytopenic purpura. Current therapy concept and introduction to pathophysiologic, clinical and diagnostic aspects].

Authors:  A Böcher; F G Hagmann; H Kreiter
Journal:  Med Klin (Munich)       Date:  1998-12-15

Review 2.  Dapsone in dermatology and beyond.

Authors:  Gottfried Wozel; Christian Blasum
Journal:  Arch Dermatol Res       Date:  2013-12-06       Impact factor: 3.017

3.  Dapsone therapy for refractory immune thrombocytopenia patients: a case series.

Authors:  Ji Yun Lee; Jeong-Ok Lee; Joo Young Jung; Soo-Mee Bang
Journal:  Blood Res       Date:  2017-06-22

4.  Dapsone therapy for immune thrombocytopenic purpura: old but still unfamiliar.

Authors:  Jaewoo Song
Journal:  Blood Res       Date:  2017-06-22

5.  Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients.

Authors:  Clémentine Estève; Maxime Samson; Alexandre Guilhem; Barbara Nicolas; Vanessa Leguy-Seguin; Sabine Berthier; Bernard Bonnotte; Sylvain Audia
Journal:  PLoS One       Date:  2017-10-30       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.